EuroQol PhD Network

Get ready! There’s just two weeks to go until the 9th EuroQol Academy 2025 and 5th ECR Meeting 2025 takes place in Barcelona, Spain 🇪🇸 This year, the Academy meeting will focus on the theme of “bolt-ons” with three sessions dedicated to exploring: 👉 Development and implementation of bolt-ons 👉 Recent studies that have developed and tested specific bolt-on dimensions 👉 Evidence and challenges associated with valuing bolt-ons We’ll see you there 👋 #EuroQolAcademy2025 #EQ5D #HealthEconomics #HealthcareResearch

Welcome to join us: Date: 24 Feb 2025 (Mon) Time: 11:00 CET (Singapore time 18:00) Zoom link: https://lnkd.in/gMPRq9ZU

Happy to share our latest publication in Value in Health, "The psychometric properties of the EQ-HWB and EQ-HWB-S in patients with breast cancer: a comparative analysis with EQ-5D-5L, FACT-8D, and SWEMWBS." Always a pleasure to collaborate with Fredrick Dermawan Purba and Clara Mukuria !

🎉 NOV 08, 2024 — A significant milestone reached! Today, I successfully defended my thesis, marking the completion of an unforgettable chapter in my PhD journey. Two guiding principles from the defence that I’ll carry forward: 1️⃣ “Stay objective — never fall in love with your thesis (research). Approach your work as an external evaluator, always considering both strengths and limitations.” 2️⃣ “As an independent scientist, seek truth through rigorous, unbiased research, always in service of advancing patient care.” I’m deeply grateful to my mentors, advisors, and committee members for their invaluable support, especially my thesis advisors, TAC, Chair, and examiners who challenged and encouraged me at every step. Your insights have pushed me to grow in ways I never anticipated, both professionally and personally. To my incredible parents, professors and friends from both NUS Public Health and Nursing who celebrated this milestone with thoughtful gifts (champagne and flowers [Yes, 🇳🇱 style], 先苦后甜 combo, and Norway blessings) — thank you so much to all for being there to share this moment. 🌟 Looking ahead, I’m excited to embark on the next chapter, committed to driving impactful, patient-centred research forward.

📣 Final call to register! Tomorrow, Nan Luo (of National University of Singapore), Nick Bansback (of The University of British Columbia) and Fatima Al Sayah, PhD (of University of Alberta) will explore MID (minimally important difference) in a PhD Network webinar. 💻 Register to attend: https://bit.ly/4dXIJAE #HealthEconomics #HealthcareResearch  #EQ5D

My third PhD paper, a psychometric validation of the Indonesian version of the FACIT-COST questionnaire for subjective financial toxicity, has been published in Health and Quality of Life Outcomes. Read it for free here! https://lnkd.in/e4jy5vPM You can also check out my other papers: - A systematic review and meta-analysis on financial toxicity and health-related quality of life: https://lnkd.in/dYkRsrg6 - A qualitative exploration of how Indonesian patients with cancer experience and cope with financial toxicity: https://lnkd.in/dH7CHbZZ

🌟 Major Milestone in Health Economics Research 🌟 I am happy to share that our latest work, titled "Systematic review reveals that EQ-5D minimally important differences decrease with increasing baseline score and may vary with treatment type", has officially been published in the Journal of Clinical Epidemiology and is now available as open access, thanks to the support from the EuroQol Research Foundation. You can access it here: https://lnkd.in/gr4bXk67. This publication serves as a pivotal step forward in health economics research, addressing frequent questions we receive from academics, healthcare professionals, and industry partners, such as: "What is the MID for EQ-5D index and EQ VAS score?" "How can it be used to determine the clinical importance of a treatment effect?" In this paper, our team conducted a comprehensive evidence synthesis on anchor-based minimal important differences (MIDs) for the EQ-5D instruments, a widely-used, generic measure of health-related quality of life, with two adult versions: EQ-5D-3L and EQ-5D-5L. We pooled 210 MID estimates from 47 studies, broken down into: - 122 estimates for EQ-5D-3L index scores - 51 estimates for EQ-5D-5L index scores - 47 estimates for EQ VAS 💡 Key Implications and Practical Applications: Our review introduces a user-friendly method using formulas and an established reference table for EQ-5D users to determine MIDs tailored to their specific contexts. This approach simplifies the process compared to the complex protocols often required in the literature. NOTE: Our latest revision made some minor updates where the nonlinear polynomial model outperformed other models in predicting the MIDs of improved scores. The formulas have also been updated accordingly (Refer to the third image), or you can derive the MID scores from Table 4 in the paper. For health deterioration, we recommend using the overall average MIDs (mean: -0.02 for EQ-5D-3L, -0.04 for EQ-5D-5L, and -6.5 for EQ VAS) to interpret changes in health status. 📊 This work advances the understanding and use of EQ-5D data, making it more accessible and actionable for healthcare decision-making. It provides a valuable benchmark for interpreting changes in health outcomes and enhances the precision of health evaluations. Lastly, a special thank you to my incredible mentors Nan Luo, Michael Herdman, and my colleagues Le Ann Chen and Jing Ying Cheng for their invaluable support. 🔬🤝 #HealthEconomics #Research #EQ5D #MID #QualityOfLife #Healthcare